There is currently a lack of organic multi-disciplinary discussion on what is truly impactful to the field of genitourinary (GU) cancers. The View on GU with Lalani and Wallis is a podcast that will integrate key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians. Importantly, Lalani and Wallis will also discuss the impact of governmental approvals and funding considerations on the GU oncology treatment landscape and provide practical considerations on the management of patients on new-to-market therapies.
The View on GU | with Lalani and Wallis
Claim This Podcastby Dr. Aly-Khan Lalani & Dr. Christopher Wallis
5.0(11 reviews)
44 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
36
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality47
Social0
YouTube0
Engagement60
Podcast Overview
There is currently a lack of organic multi-disciplinary discussion on what is truly impactful to the field of genitourinary (GU) cancers. The View on GU with Lalani and Wallis is a podcast that will integrate key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians. Importantly, Lalani and Wallis will also discuss the impact of governmental approvals and funding considerations on the GU oncology treatment landscape and provide practical considerations on the management of patients on new-to-market therapies.
Language
🇺🇲
Publishing Since
1/22/2024
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
36
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality47
Social0
YouTube0
Engagement60
6
Excellent Areas
2
Good Performance
11
Growth Opportunities
excellent
Episode Length
28 minutes
Performing excellently!
good
Show Experience
28 episodes over 1.5 years
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 20 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for The View on GU | with Lalani and Wallis
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 5, 2026
Episode 43: ASCO Annual Meeting 2026 Commentary: Bladder Cancer
<p>Dr. Aly-Khan Lalani and Dr. Chris Wallis dive into the latest bladder cancer breakthroughs, starting with crucial long-term updates from the landmark EV-302 trial. They share encouraging survival data for patients, while exploring which treatments work best if the cancer eventually progresses. The doctors also discuss the future of localized disease, reviewing strategies from the POTOMAC and SAKK trials. By highlighting a range of advanced monitoring tools, they map out how modern care is helping patients safely avoid major surgery while maintaining excellent disease control.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca<br></p><p>This podcast has been made possible through unrestricted financial support by Johnson & Johnson, Pfizer, Tolmar, AbbVie, Astellas, Eisai, Ipsen, Merck, Bayer, TerSera.</p>
June 5, 2026
Episode 42: ASCO Annual Meeting 2026 Commentary: Kidney Cancer
<p>Dr. Aly-Khan Lalani and Dr. Chris Wallis discuss how new data from the RAMPART trial strengthens the argument for administering immune-boosting therapies to patients after surgery. This episode also touches on the human side of cancer care, exploring new ways to measure patient side effects and reduce post-treatment regret through improved counseling. The doctors finish the conversation by highlighting a promising new combination of repurposed drugs that is offering renewed hope to young patients fighting Renal Medullary Carcinoma.</p><p>This podcast has been made possible through unrestricted financial support by Johnson & Johnson, Pfizer, Tolmar, AbbVie, Astellas, Eisai, Ipsen, Merck, Bayer, TerSera.</p><p><br>The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca</p>
June 5, 2026
Episode 41: ASCO Annual Meeting 2026 Commentary: Prostate Cancer
<p>Recorded in Chicago, Dr. Aly-Khan Lalani and Dr. Chris Wallis unpack a massive slate of prostate cancer data, fresh from the 2026 ASCO Annual Meeting. The conversation spans the entire disease spectrum, beginning with a deep dive into the PROTEUS trial. </p><p>Shifting to advanced disease, Dr. Lalani and Dr. Wallis discuss the TALAPRO-3 and the A-DREAM/Alliance A032101 trials. Concluding with a review of sequencing chemotherapy and radioligand therapy in the PLUDO trial, this episode provides an excellent overview of the prostate cancer landscape presented at ASCO 2026.</p><p>This podcast has been made possible through unrestricted financial support by Johnson & Johnson, Pfizer, Tolmar, AbbVie, Astellas, Eisai, Ipsen, Merck, Bayer, TerSera.</p><p><br>The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca</p>
44 total episodes available
Recent guests on The View on GU | with Lalani and Wallis
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr Winson Cheung
Guest
Similar Podcasts
Discover related shows you might enjoy
The Uromigos
The Uromigos
GU Cast
Professor Declan Murphy & Dr Renu Eapen
OncologyEducation presents MedOncNow
OncologyEducation
Prostate Cancer Update
Dr. Neil Love
ASCO Daily News
American Society of Clinical Oncology (ASCO)
Oncology Brothers
Oncology Brothers
Oncology Today with Dr Neil Love
Dr. Neil Love
Two Onc Docs
Sam and Karine
Lung Cancer Considered
IASLC
OncoPharm
John Bossaer
The Wealthy Barber Podcast
The Wealthy Barber Inc.
The Daily
The New York Times
Hidden Brain
Hidden Brain, Shankar Vedantam
The Diary Of A CEO with Steven Bartlett
DOAC
The Mel Robbins Podcast
Mel Robbins
Deep-dive analytics for The View on GU | with Lalani and Wallis
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is The View on GU | with Lalani and Wallis?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.